Pakistan Journal of
Neurological Sciences (PJNS)
Volume 13 | Issue 3

Article 3

9-2018

Hyperglycemia in acute subarachnoid hemorrhage
Maher Bano Malik
Benazir Bhutto Hospital

Jehangeer Shoro
Almana Hospitals KSA

Haris Majid Rajput
Pakistan Institute of Medical Sciences Islamabad

Follow this and additional works at: https://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Bano Malik, Maher; Shoro, Jehangeer; and Rajput, Haris Majid (2018) "Hyperglycemia in acute subarachnoid hemorrhage," Pakistan
Journal of Neurological Sciences (PJNS): Vol. 13 : Iss. 3 , Article 3.
Available at: https://ecommons.aku.edu/pjns/vol13/iss3/3

O R I G I N A L

A R T I C L E

HYPERGLYCEMIA IN ACUTE
SUBARACHNOID HEMORRHAGE

Maher Bano Malik1, Jehangeer Shoro2, Haris Majid Rajput3
Consultant Neurologist, Benazir Bhutto Hospital 2Senior Registrar, Almana Hospitals KSA
3
Assistant Professor, Pakistan Institute of Medical Sciences

1

Correspondence to: Haris Majid Rajput Email: harismajid@gmail.com
Date of submission: April 29, 2018 Date of revision: May 30, 2018 Date of acceptance: June 12, 2018

ABSTRACT
INTRODUCTION: Subarachnoid hemorrhage (SAH) is associated with high inhospital mortality and morbidity.
Hyperglycemia occurs frequently in acute medical conditions including SAH and is associated with poor outcome. The
aim of the study was to determine the frequency of Hyperglycemia in patients of subarachnoid hemorrhage.
MATERIALS AND METHODS: This was a cross sectional study that was conducted from September 3, 2013 to March
2, 2014 in Department of Neurology, Pakistan Institute of Medical Sciences, Islamabad. All patients who met the
inclusion criteria were selected for the study. Subarachnoid hemorrhage was diagnosed on the basis of plain CT scan
brain. Random blood sugar levels of all patients of SAH were checked with glucometer on the day of presentation.
RESULTS: A total of 75 patients were included. The mean age of patients was 40.05 years with standard deviation of
15.790 years. Out of 75 patients, 56 (74.67%) patients were male and 19 (25.33%) patients were female. 59
(78.67%) patients with subarachnoid hemorrhage had hyperglycemia while 16 (21.33%) patients had no
hyperglycemia.
CONCLUSION: In our study hyperglycemia is frequently found in patients of subarachnoid hemorrhage. Early detection
and treatment of hyperglycemia should be a part of initial management so as to minimize the mortality.

INTRODUCTION: Subarachnoid hemorrhage is an
acute, critical medical emergency, with incidence of 9
per 100,000 person- years. 85 % of cases of
subarachnoid hemorrhage are due to rupture of
cerebral aneurysms. Mortality for posterior circulation
aneurysms is (10-15% for all aneurysms) higher as
compared to anterior circulation aneurysms1.
Clinical features of subarachnoid hemorrhage are
severe and generalized, thunderclap headache,
vomiting, neck stiffness, loss of consciousness,
decerebrate posture, jerking of limbs or deficit of
extremities2. Common complications are rebleed,
hydrocephalus and reactive vasospasm3. Diagnosis
can be made on CT brain, MRA is valuable with 96.7 %
sensitivity in detection of intracranial aneurysm.4
Definitive treatment is obliteration of aneurysm via
endovascular procedures or surgical clipping1, external
ventricular drains prevent secondary hydrocephalus5.
Hyperglycemia occurs frequently in aneurysmal
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subarachnoid hemorrhage and is associated with
delayed cerebral ischemia and poor out come6.
Worldwide various studies have identified the frequency
and impact of hyperglycemia on the outcome in the
patients of subarachnoid hemorrhage but very few local
studies are available in even determining the frequency
of this commonly prevalent condition in patients of
subarachnoid hemorrhage.
The aim of the study was to detect the frequency of
hyperglycemia in patients of subarachnoid hemorrhage
in our setup to generate the data in local population to
emphasize checking the plasma glucose levels as a
routine part of investigations in SAH.
MATERIALS AND METHODS:
This was a descriptive case study conducted in the
Department of Neurology, Pakistan Institute of Medical
Sciences, Islamabad for six months from September 3,
2013 to March 02, 2013 after taking permission from
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ethical committee of hospital. A total of 75 patients of
subarachnoid hemorrhage were enrolled using non
probability consecutive sampling. Sample size was
calculated using WHO sample size calculator. An
informed written consent was taken from all the
patients. All patients of both genders above 13 years of
age with subarachnoid hemorrhage (diagnosed on
basis of CT scan brain) were enrolled in this study.
Diagnostic criteria for SAH was defined on basis of CT
scan brain if any one of the following is present on CT
Brain: Hyperdensity (blood) in inter hemispheric fissure
or sylvian fissure or perimesencephalic cistern with or
without
ventricular/parenchymal
extension.
Hyperglycemia was defined as Blood glucose levels
>140 mg/dl checked with glucometer on the day of
presentation.7 Those patients who had lobar
(frontal/parietal/temporal/occipital regions of brain) or
central (brainstem/basal ganglia/thalamus) bleed on
CT scan brain and Patients having prior history of
diabetes mellitus were excluded from the study.
Patients who fulfilled the criteria as per the findings of
CT scan brain underwent detailed history and
Neurological examination. Random blood sugar levels
of all the patients of subarachnoid hemorrhage were
checked with glucometer on the day of presentation.
The data was entered on a standardized Performa. Data
was entered and analyzed using SPSS version 17.
Mean and standard deviation was calculated for
numerical
variables
(age).
Frequencies
and
percentages were calculated for categorical variables
(gender, hyperglycemia).

Out of 75 patients, 56 (74.67 %) patients were male
and 19 (25.33%) patients were females as shown in
Figure 1.
Figure no: 1 Gender of patients

24 patients were in 13-35 years of age group, 32
patients were in 36-55 years of age group and 19
patients were in 56-80 years of age group as shown in
figure 2:
Figure no: 2
Distribution of patients in age groups

RESULTS:
A total of 75 patients were included in this study. The
mean age of patients was 34.41±17.12.
The minimum age of patients was 13 years, maximum
age was 75 years, median age of patients was 44
years as shown in table 1:
Table no: 1
Age distribution of patients in years
Total no of
patients (n)

Valid

75

Missing

0

Mean age of patients in years

46.05

Median age of patients in years

44.00

Mode age of patients in years

35

Std. Deviation

15.790

Range age of patients in years

62

Minimum age of patients in years
RESULTS:
Maximum age of patients in years

59 (78.67%) patients with subarachnoid hemorrhage
had hyperglycemia while 16 (21.33%) patients did not
have hyperglycemia as shown in figure no: 3

13
75
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Figure no: 3
Hyperglycemia
hemorrhage

in

patients

with

Figure no: 4
subarachnoid

DISCUSSION:
16 patients in 13-35 years of age group had
hyperglycemia while 8 patients had no hyperglycemia,
25 patients in 36-55 years of age group had
hyperglycemia while 7 patents had no hyperglycemia
and 18 patients in 56-80 years of age group had
hyperglycemia while 1 patient had no hyperglycemia
insignificant p value of 0.083 showing insignificant
age predilection as shown in table no: 2

Age group of patients

Aneurysmal subarachnoid hemorrhage (SAH) is a
devastating disease with high morbidity and mortality
rates. Although these rates have decreased in the last
decades, due to improving institutional care8, still the
30 days case fatality rate is 35-45 percent so
subarachnoid hemorrhage is an extremely fatal subtype
of stroke.9 Prevention and treatment of neurologic
complications such as rebleeding, hydrocephalus, and
delayed cerebral ischemia (DCI) are obvious targets to
improve prognosis and can be improved with
multidisciplinary management approach10. Besides
neurologic complications, patients with SAH often have
non neurologic medical complications that can
influence outcome such as neurocardiogenic injury,
neurogenic pulmonary edema, hyperglycemia and
electrolyte imbalance11. Hyperglycemia occurs
frequently in aneurysmal subarachnoid hemorrhage and
is associated with delayed cerebral ischemia and poor
out come12. Several mechanisms have been proposed
for hyperglycemia, one possible explanation is that
following subarachnoid hemorrhage there is activation
of hypothalamo-pituitary axis which in turn activates
sympathetic nervous system leading to increase release
of stress hormones enhancing glucose metabolism.
Another possibility is activation of inflammatory
response and release of cytokines which contribute to
delayed cerebral ischemia3. Inpatient glucose levels
above 7.8 mmol/litre (140 mg/dl) are associated with
poor out come7. Plasma glucose levels during
hospitalization predict the outcome of disease and can
be effectively managed with insulin therapy13.
Hyperglycemia is common in neurologic insults such as
subarachnoid hemorrhage, traumatic brain injury and
ischemic stroke, and associated with poor clinical

Hyperglycemia
Total
Present

Absent

13-35 years of age
group

16
66.7%

8
33.3%

24
100.0%

36-55 years of age
group

25
78.1%

7
21.9%

32
100.0%

56-80 years of age
group

18
94.7%

1
5.3%

19
100.0%

Total

59
78.7%

16
21.3%

75
100.0%

p-value

0.083

43 male patients and 16 female patients had
hyperglycemia while 13 male patients and 3 female
patients had no hyperglycemia with insignificant p
value of 0.495 as shown in figure no: 4
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outcome so intensive insulin therapy (IIT) has been
suggested and used in these disorders.14 As treatment
options are available for hyperglycemia , it has attracted
increasing attention as a target for intervention,
although adequate and safe glycemic control is difficult
to achieve in patients with SAH. Because hyperglycemia
seems to be implicated in the pathway from SAH to
poor clinical outcome, insight into these mechanisms
may reveal new treatment options.15-16

clinical outcome after adjustment for age, Hunt-Hess
grade, aneurysm size, rebleeding, and cerebral
infarction due to vasospasm.
Lanzino G et al20 studied plasma glucose level in 616
patients admitted within 72 hours after SAH. Admission
glucose levels showed a statistically significant
association with Glasgow Coma Scale scores, volume of
blood on computerized tomography (CT) scans, and
level of consciousness at admission. Elevated glucose
levels at admission correlated with poor outcome. A
good recovery, as assessed by the Glasgow Outcome
Scale at 3 months, occurred in 70.2% of patients with
normal glucose levels (< or = 120 mg/dl) and in 53.7%
of patients with hyperglycemia (> 120 mg/dl) (p =
0.002). The death rates for these two groups were
6.7% and 19.9%, respectively (p = 0.001). Increased
glucose levels between Days 3 and 7 also predicted a
poor outcome; in these sub groups, good recovery was
observed in 132 (73.7%) of 179 patients who had
normal glucose levels (< or = 120 mg/dl) and 160
(49.7%) of 322 who had elevated glucose levels (>
120 mg/dl) (p < 0.0001). Death occurred in 6.7% and
20.8% of the two groups, respectively (p < 0.0001).

In our study, the mean age of patients was 46.05 years
with standard deviation of 15.790 years. 56 (74.67%)
patients were male and 19 (25.33%) patients were
female and 78.67% patients of subarachnoid
hemorrhage had hyperglycemia. These results of our
study were comparable to the results of other studies.
In a study conducted by Ghosh S et al17 showed that
of the 1090 patients included in the study, 429
(39.36%) were males. The mean age of the females
was 4 years less than that of the males. Hyperglycemia
at admission was termed as a serum glucose reading of
>140 mg/dl on admission and 869 (74.22%) patients
were found to have hyperglycemia at admission.
Patients with hyperglycemia had 20.48% chance of a
good outcome compared to a 64.85% chance of good
outcome in patients with no hyperglycemia (P <
0.0001). Patients with hyperglycemia at admission also
had a higher risk of death (20.58%).

Badjatia N et al21 showed that mean admission blood
glucose levels in higher range versus low range (176.6
+/- 40.3 mg/dL vs 162.3 +/- 47.8 mg/dL) and mean
inpatient blood glucose values (166.2 +/- 24.7 mg/dL
vs. 155.8 +/- 29.7 mg/dL) were significantly higher in
patients with vasospasm( a potentially life threatening
complication of sub arachnoid hemorrhage).
Hyperglycemia was also associated with longer length of
stay in the neurointensive care unit (14.5 +/- 7.1 days
vs. 11.6 +/- 5.4 days) and poor outcome at discharge
(modified Rankin score > or =3: 58.9% vs. 18.8%).

Kruyt ND et al18 included 17 cohort studies or clinical
trials of 4095 patients with aneurysmal subarachnoid
hemorrhage admitted within 72 hours that documented
admission glucose levels or the rate of hyperglycemia.
The mean admission glucose level was 9.3 mmol/L
(range, 7.4 to 10.9 mmol/L; 14 studies, 3373 patients)
and the median proportion of patients with
hyperglycemia was 69% (range, 29 to 100; 16 studies,
3995 patients; cutoff levels of hyperglycemia, 5.7 to
12.0 mmol/L). The pooled OR (8 studies, 2164
patients) for poor outcome associated with
hyperglycemia was 3.1 (range 2.3 to 4.3). Cutoff points
for defining hyperglycemia varied across studies (6.4 to
11.1 mmol/L), but this had no clear effect on the
observed OR for poor outcome.

Our study has some limitations that need to be
addressed.
Determination
of
association
of
hyperglycemia with subarachnoid hemorrhage is sparse
in literature and this study should be taken as an initial
step in determining this association in our local
population. Extrapolation of these data should therefore
be done in the light of this limitation, although the
results have shown that the relationship between
hyperglycemia and SAH is robust and consistent.

In another study conducted by Wartenberg KE et al19
found that hyperglycemia (>11.1 mmol/L) was present
in 30% of patients at admission. Other frequent medical
complications observed were temperature >38.3
degrees C (54%), followed by anemia (36%),
hypertension (>160 mm Hg systolic; 27%),
hypernatremia >150 mmol/L (22%), pneumonia
(20%), hypotension (<90 mm Hg systolic, 18%),
pulmonary edema (14%), and hyponatremia <130
mmol/L (14%). Out of these abnormalities, Fever,
anemia and hyperglycemia significantly predicted poor
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CONCLUSION:
In our study significant number of patients of
subarachnoid hemorrhage had hyperglycemia at
hospital admission and this association was found to be
consistent. As hyperglycemia in acute subarachnoid
hemorrhage is a potential risk factor of delayed cerebral
ischemia and warrants poor clinical outcome so

04

VOL. 13 (3)

J U LY- S E P T E M B E R 2 0 1 8

increased plasma glucose levels in previously
normoglycemic patients of SAH should not go
underrecognised. Further studies are needed to show
the effect of hyperglycemia on poor outcome in SAH
and for confirmation of potential benefit of adequate
glycemic control after subarachnoid hemorrhage.

Neurosurg. 2018; 112: 799-811
Schertz M, Mehdaoui H, Hamlat A, Piotin M,
Banydeen R, Mejdoubi. Incidence and Mortality of
Spontaneous Subarachnoid Hemorrhage in
Martinique. Journal. PLoS ONE. 2016; 11(5):
e0155945
10. Brown RJ, Dhar R. Aneurysmal subarachnoid
hemorrhage.
J
Clin
Outcomes
Manage.
2011;18(5): 223-237.
11. Lantigua H, Ortega-Gutierrez S, Schmidt JM, Lee
K, Badjatia N, Agarwal S, Classen J, Connolly ES,
Mayer SA. Subarachnoid hemorrhage: who dies
and why? Critical Care. 2015; 19:309.
12. Ray B, Ludwig A, Yearout LK, Thompson DM,
Bohnstedt BN. Stress-Induced Hyperglycemia After
Spontaneous Subarachnoid Hemorrhage and Its
Role in Predicting Cerebrospinal Fluid Diversion.
World Neurosurg. 2017; 100:208-215.
9.

REFERENCES
1.

2.

3.

4.

5.
6.

7.

8.

Sharma S, Chandra PS, Abuzer A, Suri A, Gaikwad
S, Mishra NK. Posterior circulation aneurysms: A
10- year institutional analysis. Indian J Neurosurg.
2012;1:119-23.
Ropper AH, Samuels MA. Cerebrovascular
diseases. In: Davis JK, Sydor AM (editors). Adams
and victor’s principles of Neurology, 9th ed.
Boston, USA: Mc Graw Hill; 2009:746-845.
Kruyt ND, Biessels GJ, DeVries JH, Luitse MJA,
Vermeulen M, Rinkel GJ. Hyperglycemia in
aneurysmal subarchnoid hemorrhage: a potentially
modifiable risk factor for poor outcome. J Cereb
Blood Flow Metab. 2010;30:1577-87.
Shahzad R, Younas F. Detection and
catheterization
of
intracranial
aneurysms:
Magnetic resonance angiography versus digital
subtraction angiography. J Coll Physicians Surg
Pak. 2011;21:325- 9.
Hayat A, Rodrigues D, Crawford P, Mendelow D.
External ventricular drains- can morbidity be
reduced. Pak J Neurological Sci. 2009;4:1-3.
Latorre JGS, Yichou SH, Nogueira RG, Singhal AB,
Carter BS, Ogilvy CS. Effective glycemic control
with aggressive hyperglycemia management is
associated with improved in aneurysmal
subarachnoid
hemorrhage.
Stroke.
2009;40:1644-52.
Schlenk F, Vajkoczy P, Sarrafzadeh A. Inpatient
hyperglycemia following aneurysmal subarachnoid
hemorrhage and glucose management. Neurocrit
Care. 2009;11:56-63.
Abdulhasan YB, Abdulraheem N, Simoneau G,
Angle MR, Teitelbaum J. Mortality after
spontaneous subarachnoid hemorrhage. World

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

13. Schmutzhard E, Rabinstein AA. Spontaneous
subarchnoid
hemorrhage
and
glucose
management. Neurocrit Care. 2011;15:281-6.
14. Godoy DA, Soler C, Videtla W, Fuenzalida LC,
Paranhos J, Costilla M, Pinero G, Jibaja M.
Hyperglycemia in nondiabetic patients during the
acute phase of stroke. Arq Neuro psiquiatr.
2012;70(2):134-139
15. Hughes PD, Becker GJ. Screening for intracranial
aneurysms in autosomal dominant polycystic
kidney
disease.
Nephrology
(Carlton).
2003;8(4):163-70.
16. Wermer MJ, Koffijberg H, van der Schaaf IC.
Effectiveness and costs of screening for aneurysms
every 5 years after subarachnoid hemorrhage.
Neurology. 2008;70(22):2053-62.
17. Ghosh S, Dey S, Maltenfort M, Vibbert M, Urtecho
J, Rincon F. Impact of Hunt-Hess grade on the
glycemic status of aneurysmal subarachnoid
hemorrhage
patients.
Neurol
India.
2012;60(3):283-7.
18. Kruyt ND, Biessels GJ, de Haan RJ, Vermeulen M,
Rinkel GJ, Coert B. Hyperglycemia and clinical
outcome
in
aneurysmal
subarachnoid
hemorrhage:
a
meta-analysis.
Stroke.
2009;40(6):e424-30.
19. Wartenberg KE, Schmidt JM, Claassen J, Temes
RE, Frontera JA, Ostapkovich N. Impact of medical
complications on outcome after subarachnoid
hemorrhage. Crit Care Med. 2006;34(3):617-23.
20. Lanzino G, Kassell NF, Germanson T, Truskowski L,
Alves W. Plasma glucose levels and outcome after
aneurysmal
subarachnoid
hemorrhage.
J
Neurosurg. 1993;79(6):885-91.

05

VOL. 13 (3)

J U LY- S E P T E M B E R 2 0 1 8

21. Badjatia N1, Topcuoglu MA, Buonanno FS, Smith
EE, Nogueira RG, Rordorf GA. Relationship
between
hyperglycemia
and
symptomatic
vasospasm after subarachnoid hemorrhage. Crit
Care Med. 2005;33(7):1603-9.

29. Mamary AJ, Kondapaneni S, Vance GB, Gaughan
JP, Martin UJ, Criner GJ. Survival in patients
receiving prolonged ventilation: factors that
influence
outcome.
Clin
Med
Insights
CircRespirPulm Med. 2011;5:17-26.

27. Vincent JL. Relevance of albumin in modern
critical care medicine. Best Pract Res
ClinAnaesthesiol. 2009;23(2):183-191.
28. SapijaszkoMJ, Brant R, Sandham D, Berthiaume Y.
Nonrespiratory predictor of
mechanical ventilation dependency in intensive care
unit patients. Crit Care Med.
1996;24(4):601-607.

Conflict of interest: Author declares no conflict of interest.
Funding disclosure: Nil
Author’s contribution:
Maher Bano Malik; data collection, data analysis, manuscript writing, manuscript review
Jehangeer Shoro; data collection, data analysis, manuscript writing
Haris Majid Rajput; data collection, data analysis, manuscript writing

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

06

VOL. 13 (3)

J U LY- S E P T E M B E R 2 0 1 8

